Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Deloitte
Merck
McKesson
Covington
Accenture
Colorcon
Dow
Novartis

Generated: August 23, 2017

DrugPatentWatch Database Preview

Medac Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for MEDAC PHARMA INC, and what generic alternatives to MEDAC PHARMA INC drugs are available?

MEDAC PHARMA INC has one approved drug.

There is one US patent protecting MEDAC PHARMA INC drugs.

There are twenty-four patent family members on MEDAC PHARMA INC drugs in nineteen countries.

Summary for Applicant: Medac Pharma Inc

Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-009Jul 10, 2014DISCNNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-002Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-003Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-008Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
Medac Pharma Inc
RASUVO
methotrexate
SOLUTION;SUBCUTANEOUS205776-006Jul 10, 2014RXNoNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Medac Pharma Inc Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2008009476► Subscribe
Ukraine95488► Subscribe
Japan2009544636► Subscribe
Slovenia2046332► Subscribe
Japan5683810► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Novartis
McKesson
Baxter
Healthtrust
Cantor Fitzgerald
QuintilesIMS
Medtronic
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot